The Vanguard Group, Inc. ( IRSH)

Form 8.3 – The Vanguard Group, Inc.: Mural Oncology plc 04-Aug-2025 / 15:44 GMT/BST

You might also be interested in reading EQS-News: GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat.